Published in J Skin Cancer on November 25, 2012
Skin cancers after organ transplantation. N Engl J Med (2003) 6.65
Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med (2000) 6.65
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Non-melanoma skin cancer. Lancet (2010) 4.11
Excision margins in high-risk malignant melanoma. N Engl J Med (2004) 3.94
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol (1999) 3.19
Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med (2012) 2.98
Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol (2000) 2.36
Melanomas in renal transplant recipients. Br J Dermatol (2006) 1.85
The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation (1996) 1.75
Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer (1997) 1.71
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant (2008) 1.65
Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med (2003) 1.53
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation (2004) 1.40
Malignant melanoma in renal-transplant recipients. Lancet (1981) 1.33
Malignant melanoma in organ allograft recipients. Transplantation (1996) 1.22
Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg (2010) 1.16
Transmission of donor melanoma by organ transplantation. Lancet Oncol (2010) 1.15
Transplantation of malignant melanoma with cadaver kidney. Transplantation (1972) 1.14
Donor transmitted malignancies. Ann Transplant (2004) 1.13
Melanoma in solid organ transplant recipients. Am J Transplant (2010) 1.11
FATAL HOMOTRANSPLANTED MELANOMA: A CASE REPORT. Cancer (1965) 1.03
Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol (2011) 0.97
De novo malignances in pediatric organ transplant recipients. Pediatr Transplant (1998) 0.95
Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant (2004) 0.95
Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation (2000) 0.92
Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation. Transplantation (1998) 0.91
Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol (2006) 0.86
Cancer after transplantation. World J Surg (1986) 0.86
Remission of transplanted melanoma--clinical course and tumour cell characterisation. Clin Transplant (1997) 0.85
Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims. Transplantation (2012) 0.84
Melanoma in organ transplant recipients: the old enemy finds a new battleground. Australas J Dermatol (2007) 0.83
The transmission of donor-derived malignant melanoma to a renal allograft recipient. Clin Transplant (2006) 0.83
Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks. Br J Dermatol (2007) 0.83
Metastatic melanoma within a transplanted kidney: a case report. Transplant Proc (2004) 0.82
Metastatic malignant melanoma transplanted via a renal homograft: a case report. Cancer (1978) 0.81
Use of microsatellite analysis in detection of tumor lineage as a cause of death in a liver transplant patient. Arch Pathol Lab Med (2006) 0.81
Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma. Transplantation (2003) 0.80
Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transpl Int (2010) 0.79
Inadvertent transplantation of a melanoma. Transplantation (1980) 0.79
Identification of donor melanoma in a renal transplant recipient. Diagn Mol Pathol (1992) 0.76
Non-melanoma skin cancer. Lancet (2010) 4.11
Association between functional polymorphism in EGF gene and malignant melanoma. Lancet (2002) 2.48
Oral hedgehog-pathway inhibitors for basal-cell carcinoma. N Engl J Med (2012) 1.19
Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol (2005) 1.17
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res (2008) 1.05
Management of high-risk squamous cell carcinoma of the skin. Expert Rev Anticancer Ther (2011) 1.02
Focus on Basal cell carcinoma. J Skin Cancer (2010) 0.96
Polymorphism in the nuclear excision repair gene ERCC2/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma. Hum Mutat (2005) 0.91
Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system. Cancer Lett (2003) 0.89
Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser. J Am Acad Dermatol (2006) 0.83
Associations between UVR exposure and basal cell carcinoma site and histology. Cancer Lett (2004) 0.81
Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation (2008) 0.81
The role of ingenol mebutate in the treatment of actinic keratoses. Dermatol Ther (Heidelb) (2012) 0.80
PTCH polymorphism is associated with the rate of increase in basal cell carcinoma numbers during follow-up: preliminary data on the influence of an exon 12-exon 23 haplotype. Environ Mol Mutagen (2004) 0.79
Use of photodynamic therapy for treatment of actinic keratoses in organ transplant recipients. Biomed Res Int (2012) 0.76
Defining locally advanced basal cell carcinoma and integrating smoothened inhibitors into clinical practice. Curr Opin Oncol (2016) 0.75
A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity. Acta Derm Venereol (2017) 0.75
Increasing capacity for skin surveillance in a transplant review clinic. Transplantation (2014) 0.75
Medical image. Systemic retinoids for recurrent keratoacanthomas. N Z Med J (2013) 0.75
Actinic Keratoses, Actinic Field Change and Associations with Squamous Cell Carcinoma in Renal Transplant Recipients in Manchester, UK. Acta Derm Venereol (2015) 0.75
Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma. J Am Acad Dermatol (2009) 0.75
Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management. Acta Derm Venereol (2017) 0.75
Basal cell carcinoma: genetic homogeneity in a tumour type displaying phenotypic diversity. Eur J Hum Genet (2006) 0.75